where on the thigh to inject semaglutide Injection Technique Guide Semaglutide Injection Sites: Abdomen vs.

Clinical trials highlighted a 12.4% average weight reduction

DOI: 10.1186/s12970-017-0173-z

Side effects were generally dose-dependent starting on a lower dose and gradually increasing may help reduce gastrointestinal discomfort

Of these, 1,956 gastrointestinal reports were for exenatide (9.19%), 2,891 for liraglutide (13.58%), 10,757 for dulaglutide (50.55%), 182 for lixisenatide (0.86%), and 5,567 (26.16%) for semaglutide ( Figure 1 )

Combining a GLP-1 agonist with a sympathomimetic raises theoretical concerns around heart rate elevation, blood pressure increases, and potential arrhythmia risk

Months 79 6 mg/week Reserved for plateaus from Months 46